Showing results (431-440 of 763) with videos related to

Sort By:
Pageof 77
Scientific Reports|July 14, 2023
SARS-CoV-2 spike protein induces lung endothelial cell dysfunction and thrombo-inflammation depending on the C3a/C3a receptor signallingLuca Perico, Marina Morigi, Anna Pezzotta, et al.
The American Journal of Pathology|December 7, 2006
Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodelingMarina Morigi, Simona Buelli, Cristina Zanchi, et al.
Nephron|April 28, 2021
Characterization of a Rat Model of Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Crescentic GlomerulonephritisDomenico Cerullo, Daniela Rottoli, Daniela Corna, et al.
The American Journal of Pathology|June 21, 2011
Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patientsAnna Caroli, Luca Antiga, Sara Conti, et al.
The CRISPR Journal|April 19, 2019
CRISPR-Cas9-Mediated Correction of the G189R-PAX2 Mutation in Induced Pluripotent Stem Cells from a Patient with Focal Segmental GlomerulosclerosisPiera Trionfini, Osele Ciampi, Marta Todeschini, et al.
Cells|September 13, 2025
Correction: Pezzotta et al. Low Nephron Number Induced by Maternal Protein Restriction Is Prevented by Nicotinamide Riboside Supplementation Depending on Sirtuin 3 Activation. Cells 2022, 11, 3316Anna Pezzotta, Luca Perico, Marina Morigi, et al.
Blood|October 5, 2007
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndromeCelia J Fang, Veronique Fremeaux-Bacchi, M Kathryn Liszewski, et al.
Cells|October 27, 2022
Low Nephron Number Induced by Maternal Protein Restriction Is Prevented by Nicotinamide Riboside Supplementation Depending on Sirtuin 3 ActivationAnna Pezzotta, Luca Perico, Marina Morigi, et al.
Plos One|January 26, 2016
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-AnalysisPietro Amedeo Modesti, Gianpaolo Reboldi, Francesco P Cappuccio, et al.
Kidney International|June 16, 2005
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney diseasePiero Ruggenenti, Andrea Remuzzi, Patrizia Ondei, et al.
Pageof 77